| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.22 | 0.007 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.51 | 0.008 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |